Selected Grants
Cell and Molecular Biology Training Program
Inst. Training Prgm or CMEMentor · Awarded by National Institutes of Health · 2021 - 2026Understanding the Role of Type 2 Inflammation in Prurigo Nodularis
ResearchPrincipal Investigator · Awarded by Sanofi US · 2023 - 2025GZ17-6.02 as a Novel Therapeutic Agent for Dermatologic
ResearchPrincipal Investigator · Awarded by Genzada Pharmaceuticals, LLC · 2020 - 2025IL-13Ra1 signaling in atopic dermatitis
ResearchPrincipal Investigator · Awarded by ASLAN Pharmaceuticals · 2022 - 2025Anti-fibrotic mechanisms of IL-31 blockade in prurigo nodularis
ResearchPrincipal Investigator · Awarded by Galderma · 2023 - 2024Prurigo Nodularis: Disease Burden and Rationale for Novel Therapeutics
ResearchPrincipal Investigator · Awarded by Galderma · 2022 - 2024Evaluation of novel anti-cancer agents, either alone or in combination, for activity against glioblastoma subtypes: a personalized medicine approach
ResearchPrincipal Investigator · Awarded by Genzada Pharmaceuticals, LLC · 2017 - 2024Generating Patient-Derived Gliomas within Cerebral Organoids to be Treated with Repurposed Drugs
ResearchPrincipal Investigator · Awarded by Musella Foundation For Brain Tumor Research & Information, Inc · 2021 - 2022Glioblastoma model research
ResearchPrincipal Investigator · Awarded by The Miami Foundation · 2017 - 2021Heterogeneity of EGFRvIII-positive glioblastoma and their sensitivity to AZD9291 (Osimertinib)
ResearchPrincipal Investigator · Awarded by Musella Foundation For Brain Tumor Research & Information, Inc · 2019 - 2020Organization and Function of Cellular Structure
Inst. Training Prgm or CMEMentor · Awarded by National Institutes of Health · 1975 - 2020Evaluation of VAL-083, either alone or in combination with other agents, for its activity inhibition of glioblastoma subtypes (personalized drug development)
ResearchPrincipal Investigator · Awarded by DelMar Pharmaceuticals, Inc. · 2017 - 2020Pharmacology Industry Internships for Ph.D. Students
Inst. Training Prgm or CMEParticipating Faculty Member · Awarded by American Society for Pharmacology and Experimental Therapeutics · 2017 - 2019Heterogeneity of EGFRvIII-positive glioblastoma and their sensitivity to AZD9291 (Osimertinib)
FellowshipPrincipal Investigator · Awarded by Musella Foundation For Brain Tumor Research & Information, Inc · 2018 - 2018Curtana Pharmacueticals Sponsored Research Agreement
ResearchPrincipal Investigator · Awarded by Curtana Pharmaceuticals, Inc. · 2016 - 2017Evaluation of AZD9291 in Glioblastoma patients with activated EGFR
Clinical TrialPrincipal Investigator · Awarded by National Institutes of Health · 2015 - 2016Targeting GBMs with Activated EGFR with third-generation, brain-penetrating AZD9291
FellowshipPrincipal Investigator · Awarded by Musella Foundation For Brain Tumor Research & Information, Inc · 2016 - 2016Summer Research fellowship for two undergraduate Pre-Med Students
ResearchPrincipal Investigator · Awarded by Musella Foundation For Brain Tumor Research & Information, Inc · 2014 - 2015Truncated NK1R in GBM: Pharmacology and Relationship with Patient Survival
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2012 - 2015Isolation of stem cells from glioblastoma xenografts with activated EGFR
ResearchPrincipal Investigator · Awarded by Musella Foundation For Brain Tumor Research & Information, Inc · 2014 - 2014Molecular Basis of Postoperative Delirium in the Elderly
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2003 - 2010Aging And G Protein Coupled Receptors In Human Heart
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 1998 - 2006Same
ResearchCo Investigator · Awarded by National Institutes of Health · 1997 - 2002Function Of Human Substance P Receptor
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 1995 - 2001Desensitization Of B-Adrenoceptors During Cardiopulmonary
ResearchCo-Principal Investigator · Awarded by National Institutes of Health · 1997 - 1999Function Of Substance P Receptor
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 1995 - 1999Function Of Human Substances P Receptor
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 1995 - 1999Transcriptional Regulation Of Human 1a-Adrenoceptors
ResearchCo-Principal Investigator · Awarded by National Institutes of Health · 1996 - 1999Molecular Characterization Of Human Alc-Adrenergic Recept
ResearchCo-Principal Investigator · Awarded by National Institutes of Health · 1996 - 1999Excitatory Amino Acids In Ovine Fetal Brain Injury
ResearchCo-Principal Investigator · Awarded by National Institutes of Health · 1996 - 1998Aging And G Protein-Coupled Receptor Signaling In Human
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 1996 - 1997External Relationships
- GBM Pharma, Inc. This organization was closed this year (2023) and I incorporated another company known as Glioblastoma Therapeutics Inc
- Glioblastoma Foundation
- Glioblastoma Foundation
This faculty member (or a member of their immediate family) has reported outside activities with the companies, institutions, or organizations listed above. This information is available to institutional leadership and, when appropriate, management plans are in place to address potential conflicts of interest.